Results 171 to 180 of about 23,301 (196)

Mantle cell lymphoma

Hematology/Oncology Clinics of North America, 2010
openaire   +1 more source

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly  

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

New England Journal of Medicine, 2020
André Goy, Ian Flinn, Brian Hill
exaly  

Mantle cell lymphoma

Seminars in Cancer Biology, 2011
openaire   +2 more sources

Colonic Mantle Cell Lymphoma

Clinical Gastroenterology and Hepatology, 2012
Bouwens, M.W.E., Masclee, A.A.M., Sanduleanu, S.   +2 more
openaire   +3 more sources

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage

Cancer Cell, 2016
Angelika Merkel, Renee Beekman, Silvia Bea   +2 more
exaly  

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network

Annals of Oncology, 2013
Pavel Klener, Annalisa Chiappella, Lukas Smolej   +2 more
exaly  

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Lancet, The, 2016
Isabelle D'Hondt, Simon Rule, Isabelle Bence-Bruckler   +2 more
exaly  

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Lancet, The, 2016
Wolfram Klapper, Eva Hoster, Bernd Metzner   +2 more
exaly  

Acalabrutinib in mantle cell lymphoma

The Lancet, 2018
Prashant, Kapoor, Stephen M, Ansell
openaire   +2 more sources